CD4 and neoplasm: Comprehensive IHC analyses revealed that TAX2 peptide immune mode of action mostly relies on adaptive immunity, since it does not only increases the number of infiltrating CD4+ T lymphocytes, but also stimulates deeper T-cell infiltration within the tumor mass.